Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: July 2021

Infobird Co. Ltd. (NASDAQ: IFBD) Remains Committed to Maintaining Strong Technological Advantages through R&D, Innovation

Posted on July 14, 2021 by MissionIR

Infobird has continually invested significant resources in R&D to support its existing business, enhance its service and product offerings, incubate new technological breakthroughs and business initiatives, and maintain its technological advantages IFBD acknowledges that it is through innovation and continuous … Continue reading →

Posted in Infobird Software Co. Ltd. IFBD | Leave a comment

MissionIRNewsBreaks – XPhyto Therapeutics Corp.’s (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Covid-ID Lab Filling Existing Market Gap

Posted on July 13, 2021 by MissionIR

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience technology accelerator, recently announced that its distribution, storage and logistics partner, Max Pharma GmbH, began selling and delivering its 25-minute COVID-19 RT-PCR test system (“Covid-ID Lab”) in Germany on May … Continue reading →

Posted in XPhyto Therapeutics Corp. XPHYF | Leave a comment

MissionIRNewsBreaks – Splash Beverage Group Inc.’s (NYSE American: SBEV) Go-Anywhere Copa Di Vino Positions Company as Post-COVID World Moves Forward

Posted on July 13, 2021 by MissionIR

Splash Beverage Group (NYSE American: SBEV), a portfolio company of successful beverage brands, is positioned with a unique offering as the wine market moves forward post COVID-19. Under previous quarantine and lockdown restrictions brought on by the pandemic, people spent … Continue reading →

Posted in Splash Beverage Group Inc. SBEV | Leave a comment

MissionIRNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Promising Study Results for Game-Changing Technology

Posted on July 13, 2021 by MissionIR

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from sleep-disordered breathing, today announced results from a national study it commissioned to asses patients’ airway function and obstructive … Continue reading →

Posted in Vivos Therapeutics Inc. VVOS | Leave a comment

MissionIRNewsBreaks – Nextech AR Solutions Corp. (OTCQB: NEXCF) (NEO: NTAR) (CSE: NTAR) (FSE: N29) CEO to Participate in Virtual InvestorConferences.com

Posted on July 13, 2021 by MissionIR

Nextech AR Solutions (OTCQB: NEXCF) (NEO: NTAR) (CSE: NTAR) (FSE: N29) CEO and founder Evan Gappelberg will be presenting live at VirtualInvestorConferences.com. Gappelberg’s presentation is scheduled for Aug. 5, 2021, at 9:30 a.m. ET. The company, a diversified leading provider … Continue reading →

Posted in Nextech AR Solutions Corp. NEXCF | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Considerable IP Portfolio with Patent Protection in Japan

Posted on July 13, 2021 by MissionIR

Lexaria Bioscience Corp. (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced an additional expansion of its intellectual property (“IP”) portfolio with its first-ever patent granted in Japan. According to the update, “Stable ready-to-drink beverage compositions comprising … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

SRAX Inc. (NASDAQ: SRAX) Solidifies Position as Investor Industry Leader, Expands Text and Email Capabilities, Launches Microcaps.com

Posted on July 13, 2021 by MissionIR

Staying connected to retail investors is critical in today’s market, considering retailers poured almost $28 billion into the stock market in June SRAX offers suite of products designed to improve due diligence, transparency, and communications between investors, corporations SRAX’s Sequire … Continue reading →

Posted in SRAX, Inc. SRAX | Leave a comment

Powerful Antioxidant Nanoemulsion Development Lights Up the Profile of Pressure BioSciences Inc. (PBIO)

Posted on July 13, 2021 by MissionIR

Life sciences technology innovator Pressure BioSciences (OTCQB: PBIO) specializes in the use of ultra-high pressure technologies to innovate unexpected and potent solutions for a wide variety of industries, including biomarker and target discovery, forensics, counter-bioterror applications, improved quality and economics … Continue reading →

Posted in Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Files Patent as Part of Digital Therapeutics Strategy

Posted on July 13, 2021 by MissionIR

Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, has filed a new provisional patent application to protect its proprietary digital therapeutics platform; the patent is the company’s 13th. In addition, the company is also advancing … Continue reading →

Posted in Cybin Inc. CLXPF | Leave a comment

Rock-Solid Business Model, String of Big Box Contracts Point to Another Record-Breaking Year For Sustainable Green Team, Ltd. (SGTM)

Posted on July 13, 2021 by MissionIR

SGTM transforms storm, hurricane waste into environmentally beneficial products that enhance, fortify the earth Company on solid growth trajectory with string of lucrative contracts awarded in recent months Clients include municipal governments, large commercial retailers including The Kroger Co, Circle … Continue reading →

Posted in Sustainable Green Team Ltd. SGTM | Leave a comment